[{"Assets_0_FY_USD":2437203000.0,"CommonStockSharesOutstanding_0_FY_shares":84562000.0,"EarningsPerShareBasic_4_FY_USD":8.74,"EarningsPerShareDiluted_4_FY_USD":8.6,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":755546000.0,"NetIncomeLoss_4_FY_USD":744845000.0,"NetIncomeLossConverted_4_FY_USD":744844000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_4_FY_USD":3215360000.0,"StockholdersEquity_0_FY_USD":689992000.0,"StockholdersEquityConverted_0_FY_USD":689992000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":86572000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":85200000.0,"Ticker":"IDXX","CIK":"874716","name":"IDEXX LABORATORIES INC \/DE","OfficialName":"IDEXX Laboratories Inc. Common Stock","form":"10-K","period":"20211231","fy":"2021.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"42180715521.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"SP500","filed":"20220216"}]